Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study

References

• PoyurovskyMAcute antipsychotic-induced akathisia revisitedBr J Psychiatry20101962899120118449
   PubMed Web of Science ®Google Scholar
• Cem AtbaşogluESchultzSKAndreasenNCThe relationship of akathisia with suicidality and depersonalization among patients with schizophreniaJ Neuropsychiatry Clin Neurosci200113333634111514639
   PubMed Web of Science ®Google Scholar
• DuncanEJAdlerLAStephanidesMSanfilipoMAngristBAkathisia and exacerbation of psychopathology: a preliminary reportClin Neuropharmacol200023316917310895402
   PubMed Web of Science ®Google Scholar
• PraMvan PuttenTYaleCPredicting individual responses to drug treatment in schizophreniaJ Nerv Ment Dis19761253177183
   Google Scholar
• van PuttenTWhy do schizophrenic patients refuse to take their drugs?Arch Gen Psychiatry197431167724151750
   PubMed Web of Science ®Google Scholar
• LeeYWKimJHAnnJHSubjective well-being in patients with schizophrenia treated with atypical antipsychotics: the impact of psychopathology and adverse drug effectsClin Psychopharmacol Neurosci201083149155
   Google Scholar
• TaylorDPatonCKapurSThe Maudsley Prescribing Guidelines in Psychiatry12th edWest SussexJohn Willey & Sons20158889
   Google Scholar
• PoyurovskyMPashinianAWeizmanRFuchsCWeizmanALow-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trialBiol Psychiatry200659111071107716497273
   PubMed Web of Science ®Google Scholar
• ChenYHLeeHCLinHCPrevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based studySchizophr Res20091081–319119619171465
   PubMed Web of Science ®Google Scholar
• PfefferGChouinardGMargoleseHCGabapentin in the treatment of antipsychotic-induced akathisia in schizophreniaInt Clin Psychopharmacol200520317918115812271
   PubMed Web of Science ®Google Scholar
• SullivanMAWilburRGabapentin pharmacotherapy for antipsychotic-induced akathisia: single-patient experiment and case reportTher Adv Psychopharmacol20144210010224688760
   PubMedGoogle Scholar
• TakeshimaMIshikawaHKikuchiYKanbayashiTShimizuTSuccessful management of clozapine-induced akathisia with gabapentin enacarbil: a case reportClin Psychopharmacol Neurosci201816334634830121987
   PubMed Web of Science ®Google Scholar
• LimaARSoares-WeiserKBacaltchukJBarnesTRBenzodiazepines for neuroleptic-induced acute akathisiaCochrane Database Syst Rev20021CD001950
   Google Scholar
• Garcia-BorregueroDLarrosaOde La LlaveYVergerKMas-ramonXHernandezGTreatment of restless legs syndrome with gabapentin: a double-blind, cross-over studyNeurology200259101573157912451200
   PubMed Web of Science ®Google Scholar
• ManeufYPGonzalezMISuttonKSChungFZPinnockRDLeeKCellular and molecular action of the putative GABA-mimetic, gabapentinCell Mol Life Sci200360474275012785720
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edVirginiaAmerican Psychiatric Publishing2013
   Google Scholar
• BarnesTRA rating scale for drug-induced akathisiaBr J Psychiatry19891546726762574607
   PubMed Web of Science ®Google Scholar
• OverallJEGormanDRThe Brief Psychiatric Rating ScalePsychol Rep1962103799812
   Web of Science ®Google Scholar
• Astellas Pharma IncRegnite^® Tablets 300 mg Interview Form, 7th versionTokyo2018 Available from: https://amn.astellas.jp/jp/di/list/reg/pi_reg.pdfAccessed November 14, 2018 Japanese
   Google Scholar
• AdlerLAngristBPeselowECorwinJMaslanskyRRotrosenJA controlled assessment of propranolol in the treatment of neuroleptic-induced akathisiaBr J Psychiatry198614942452877708
   PubMed Web of Science ®Google Scholar
• KramerMSGorkinRADijohnsonCShevesPPropranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled studyBiol Psychiatry19882478238272906547
   PubMed Web of Science ®Google Scholar
• LaoutidisZGLuckhausC5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysisInt J Neuropsychopharmacol201417582383224286228
   PubMed Web of Science ®Google Scholar
• PoyurovskyMWeizmanRWeizmanAMirtazapine – a multifunctional drug: low dose for akathisiaCNS Spectr20111626322789775
   PubMed Web of Science ®Google Scholar
• StryjerRRosenzcwaigSBarFUlmanAMWeizmanASpivakBTrazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover studyClin Neuropharmacol201033521922220838215
   PubMed Web of Science ®Google Scholar
• WeissDAizenbergDHermeshHCyproheptadine treatment in neuroleptic-induced akathisiaBr J Psychiatry199516744834868829717
   PubMed Web of Science ®Google Scholar
• FischelTHermeshHAizenbergDCyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind studyJ Clin Psychopharmacol200121661261511763011
   PubMed Web of Science ®Google Scholar
• AvitalAGross-IsseroffRStryjerRHermeshHWeizmanAShilohRZolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind studyEur Neuropsychopharmacol200919747648219342206
   PubMed Web of Science ®Google Scholar
• MillerCHFleischhackerWWManaging antipsychotic-induced acute and chronic akathisiaDrug Saf2000221738110647977
   PubMed Web of Science ®Google Scholar
• MiodownikCLernerVStatsenkoNVitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a random-ized, double-blind, controlled studyClin Neuropharmacol2006292687216614537
   PubMed Web of Science ®Google Scholar
• InoueYUchimuraNKurodaKHirataKHattoriNLong-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patientsProg Neuropsychopharmacol Biol Psychiatry201236225125722036917
   PubMed Web of Science ®Google Scholar
• EllenbogenALTheinSGWinslowDHA 52-week study of gabapentin enacarbil in restless legs syndromeClin Neuropharmacol201134181621242741
   PubMed Web of Science ®Google Scholar
• GulsunMDorukAMirtazapine-induced akathisiaJ Clin Psychopharmacol2008284467
   PubMed Web of Science ®Google Scholar
• AggarwalAKhandelwalAGargAJilohaRCAkathisia associated with mianserinJ Clin Psychopharmacol201030333833920473077
   PubMed Web of Science ®Google Scholar
• OginoSMiyamotoSMiyakeNYamaguchiNBenefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive functionPsychiatry Clin Neurosci2014681374924102938
   PubMed Web of Science ®Google Scholar